Acute myocardial infarction due to coronary stent thrombosis in a symptomatic COVID-19 patient

[1] Shi S(2020)Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China JAMA Cardiol 101 1738-1747

[2] Barnes M(2015)Acute myocardial infarction and influenza: a meta-analysis of case-control studies Heart 15 168-175

[3] Hebsur S(2014)Influenza and coronary artery disease: exploring a clinical association with myocardial infarction and analyzing the utility of vaccination in prevention of myocardial infarction Rev Cardiovasc Med 61 591-598

[4] Guan X(2012)Association of influenza virus infection and inflammatory cytokines with acute myocardial infarction Inflamm Res 34 11-18

[5] Madjid M(2007)Systemic infections cause exaggerated local inflammation in atherosclerotic coronary arteries: clues to the triggering effect of acute infections on acute coronary syndromes Tex Heart Inst J 13 34-45

[6] Engelmann B(2013)Thrombosis as an intravascular effector of innate immunity Nat Rev Immunol 382 e38-82

[7] Massberg S(2020)Coagulopathy and antiphospholipid antibodies in patients with Covid-19 N Engl J Med 39 79-823

[8] Zhang Y(2020)Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19) JAMA Cardiol 107 816-349

[9] Inciardi RM(2020)Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China Clin Res Cardiol 109 339-undefined

[10] Li B(2020)COVID-19 and the heart Circ Res undefined undefined-undefined

[1] Shi S(2020)Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China JAMA Cardiol 101 1738-1747

[2] Barnes M(2015)Acute myocardial infarction and influenza: a meta-analysis of case-control studies Heart 15 168-175

[3] Hebsur S(2014)Influenza and coronary artery disease: exploring a clinical association with myocardial infarction and analyzing the utility of vaccination in prevention of myocardial infarction Rev Cardiovasc Med 61 591-598

[4] Guan X(2012)Association of influenza virus infection and inflammatory cytokines with acute myocardial infarction Inflamm Res 34 11-18

[5] Madjid M(2007)Systemic infections cause exaggerated local inflammation in atherosclerotic coronary arteries: clues to the triggering effect of acute infections on acute coronary syndromes Tex Heart Inst J 13 34-45

[6] Engelmann B(2013)Thrombosis as an intravascular effector of innate immunity Nat Rev Immunol 382 e38-82

[7] Massberg S(2020)Coagulopathy and antiphospholipid antibodies in patients with Covid-19 N Engl J Med 39 79-823

[8] Zhang Y(2020)Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19) JAMA Cardiol 107 816-349

[9] Inciardi RM(2020)Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China Clin Res Cardiol 109 339-undefined

[10] Li B(2020)COVID-19 and the heart Circ Res undefined undefined-undefined